Stockscreener 앱 받기
10.61
3.89%
-0.43
시간 외 거래:
10.80
0.19
+1.79%
전일 마감가:
$11.04
열려 있는:
$11.0696
하루 거래량:
7,723
Relative Volume:
0.26
시가총액:
$67.44M
수익:
-
순이익/손실:
$-61.23M
주가수익비율:
-0.7848
EPS:
-13.5194
순현금흐름:
$22.49M
1주 성능:
-7.17%
1개월 성능:
-13.10%
6개월 성능:
-41.28%
1년 성능:
-16.06%
1일 변동 폭
$10.60
$11.11
1주일 범위
$10.56
$11.90
52주 변동 폭
$10.56
$19.93
Assembly Biosciences Inc Stock (ASMB) Company Profile
명칭
Assembly Biosciences Inc
전화
(833) 409-4583
주소
TWO TOWER PLACE, SOUTH SAN FRANCISCO
ASMB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
10.61 | 67.44M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-20 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-09-13 | 개시 | H.C. Wainwright | Neutral |
| 2021-09-02 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-10-19 | 개시 | Truist | Buy |
| 2019-10-16 | 개시 | Mizuho | Buy |
| 2018-11-19 | 개시 | Leerink Partners | Outperform |
| 2018-10-08 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | 개시 | Robert W. Baird | Outperform |
| 2018-04-13 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | 개시 | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | 개시 | Jefferies | Buy |
| 2017-05-30 | 개시 | Chardan Capital Markets | Buy |
모두보기
Assembly Biosciences Inc 주식(ASMB)의 최신 뉴스
ASMB stock touches 52-week low at $10.8 amid market challenges - Investing.com Australia
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Update - Defense World
Is Assembly Biosciences, Inc. (ASMB) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey
10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey
ASMB stock touches 52-week low at $11.44 amid market challenges - Investing.com India
ASMB stock touches 52-week low at $11.44 amid market challenges By Investing.com - Investing.com South Africa
(ASMB) Trading Report - Stock Traders Daily
Assembly Biosciences and Gilead's genital herpes treatment gives positive results in early stage trial - MSN
Assembly Biosciences Doses First Subject in Phase 1a Trial of Hepatitis Delta Virus Therapy Candidate; Shares Up - Marketscreener.com
Assembly Biosciences Initiates Phase 1a Study Of ABI-6250, Oral Entry Inhibitor For - Nasdaq
Assembly Biosciences initiates phase 1a trial for HDV treatment candidate By Investing.com - Investing.com South Africa
Assembly Biosciences initiates phase 1a trial for HDV treatment candidate - Investing.com India
Assembly Biosciences Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus - The Manila Times
Infectious disease index recovers from -25% low, ends 2024 down 6.28% - BioWorld Online
(ASMB) Investment Analysis - Stock Traders Daily
Assembly Bio advances herpes treatment into next trial phase By Investing.com - Investing.com Nigeria
Assembly Bio advances herpes treatment into next trial phase - Investing.com
Catalent Appoints Susan Mahony, Marie-France Tschudin and Tim Walbert to its Board of Directors - citybiz
Catalent Announces New Board Appointments - Business Wire
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor ABI-1179 in Development for Recurrent Genital Herpes - The Manila Times
Can This New Once-Weekly Herpes Treatment Transform Patient Care? Phase 1a Results Reveal Breakthrough - StockTitan
Peapod Lane Capital LLC Takes $994,000 Position in Assembly Biosciences, Inc. (NASDAQ:ASMB) - MarketBeat
Biotechnology Market Size, Share, Trends Research Report 2025-2034 - PharmiWeb.com
JPMorgan Chase & Co. Boosts Holdings in Assembly Biosciences, Inc. (NASDAQ:ASMB) - Defense World
Reviewing Assembly Biosciences (NASDAQ:ASMB) and CytoDyn (OTCMKTS:CYDY) - Defense World
When the Price of (ASMB) Talks, People Listen - Stock Traders Daily
AC Immune (NASDAQ:ACIU) & Assembly Biosciences (NASDAQ:ASMB) Head-To-Head Review - Defense World
(ASMB) Technical Pivots with Risk Controls - Stock Traders Daily
Geode Capital Management LLC Has $712,000 Stock Position in Assembly Biosciences, Inc. (NASDAQ:ASMB) - Defense World
Gilead raises Assembly Bio stake to ~30% - MSN
IGM Bio stock plunges as analysts downgrade (IGMS:NASDAQ) - Seeking Alpha
ABI-4334 shows promise in hepatitis B Phase 1b trial: Data - Liver Disease News
Trend Tracker for (ASMB) - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Share Price Passes Above 200 Day Moving AverageHere's What Happened - MarketBeat
Assembly Biosciences extends lease through 2029 By Investing.com - Investing.com Nigeria
Assembly Biosciences extends lease through 2029 - Investing.com India
Brokerages Set TKO Group Holdings, Inc. (NYSE:TKO) PT at $136.79 - Defense World
Jefferies Top 2025 Stock Picks Include 5 Sizzling Large Cap Dividend Blue Chips - 24/7 Wall St.
Hedge Fund and Insider Trading News: Glenn Greenberg, Warren Buffett, Bill Ackman, D.E. Shaw, Millennium Management, Assembly Biosciences Inc (ASMB), Simon Property Group Inc (SPG), and More - Insider Monkey
Financial Analysis: Assembly Biosciences (NASDAQ:ASMB) vs. LifeVantage (NASDAQ:LFVN) - Defense World
Assembly Biosciences director Houghton buys $49,997 in stock By Investing.com - Investing.com Australia
Assembly Biosciences director Houghton buys $49,997 in stock - Investing.com India
Assembly Biosciences, Inc. (NASDAQ:ASMB) Director Acquires $49,983.22 in Stock - MarketBeat
Gilead Buys $20.1 Million of Assembly Biosciences Stock - MSN
Assembly Biosciences Inc (ASMB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.39%
0.55%
자본화:
|
볼륨(24시간):